Related Experiment Videos
Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src
N Aziz1, H Cherwinski, M McMahon
1Department of Cell Signaling, DNAX Research Institute, Palo Alto, California 94304-1104, USA.
Abstract:
Ras-activated signal transduction pathways are implicated in the control of cell proliferation, differentiation, apoptosis, and tumorigenesis, but the molecular mechanisms mediating these diverse functions have yet to be fully elucidated. Conditionally active forms of Raf, v-Src, and MEK1 were used to identify changes in gene expression that participate in oncogenic transformation, as well as in normal growth control. Activation of Raf, v-Src, and MEK1 led to induced expression of c-Myc and cyclin D1. Induction of c-Myc mRNA by Raf was an immediate-early response, whereas the induction of cyclin D1 mRNA was delayed and inhibited by cycloheximide. Raf activation also resulted in the induction of an established c-Myc target gene, ornithine decarboxylase (ODC). ODC induction by Raf was mediated, in part, by tandem E-boxes contained in the first intron of the gene. Activation of the human colony-stimulating factor 1 (CSF-1) receptor in NIH 3T3 cells leads to activation of the mitogen-activated protein (MAP) kinase pathway and induced expression of c-Fos, c-Myc, and cyclin D1, leading to a potent mitogenic response. By contrast, a mutated form of this receptor fails to activate the MAP kinases or induce c-Myc and cyclin D1 expression and fails to elicit a mitogenic response. The biological significance of c-Myc and cyclin D1 induction by Raf and v-Src was confirmed by the demonstration that both of these protein kinases complemented the signaling and mitogenic defects of cells expressing this mutated form of the human CSF-1 receptor. Furthermore, the induction of c-Myc and cyclin D1 by oncogenes and growth factors was inhibited by PD098059, a specific MAP kinase kinase (MEK) inhibitor. These data suggest that the Raf/MEK/MAP kinase pathway plays an important role in the regulation of c-Myc and cyclin D1 expression in NIH 3T3 cells. The ability of oncogenes such as Raf and v-Src to regulate the expression of these proteins reveals new lines of communication between cytosolic signal transducers and the cell cycle machinery.
Insights
Oncogenic pathways involving Raf, v-Src, and MEK1 activate cell cycle genes c-Myc and cyclin D1. This research clarifies how these signaling pathways regulate gene expression for cell growth and transformation.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Ras-activated signal transduction pathways control cell proliferation, differentiation, apoptosis, and tumorigenesis.
- The precise molecular mechanisms underlying these diverse cellular functions remain incompletely understood.
Purpose of the Study:
- To investigate gene expression changes in oncogenic transformation and normal growth control.
- To elucidate the role of Raf, v-Src, and MEK1 in regulating key cell cycle genes.
Main Methods:
- Utilized conditionally active forms of Raf, v-Src, and MEK1 to study gene expression.
- Examined the induction of c-Myc, cyclin D1, and ornithine decarboxylase (ODC).
- Employed a mutated colony-stimulating factor 1 (CSF-1) receptor to assess MAP kinase pathway involvement and used a MEK inhibitor (PD098059).
Main Results:
- Activation of Raf, v-Src, and MEK1 induced expression of c-Myc and cyclin D1.
- Raf activation led to immediate-early induction of c-Myc mRNA and delayed induction of cyclin D1 mRNA.
- The Raf/MEK/MAP kinase pathway was crucial for regulating c-Myc and cyclin D1 expression, as evidenced by inhibition with PD098059.
Conclusions:
- The Raf/MEK/MAP kinase pathway is a key regulator of c-Myc and cyclin D1 expression in NIH 3T3 cells.
- Oncogenes like Raf and v-Src establish communication between cytosolic signal transducers and the cell cycle machinery.
- Understanding these pathways offers insights into oncogenic transformation and normal cell growth control.